Woodline Partners LP

Position in ABSI — Absci Corp

CIK 1784547 San Francisco, CA

Position in ABSI

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$9,900,507

+$1,940,575 QoQ

Shares Held

3,300,169

+44.7% QoQ

Ownership

2.12%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $3,320,901,631 across 188 Biotechnology names. ABSI ranks #80 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,506,570	$243,763,932
2	TNGX	Tango Therapeutics, Inc.	8,000,013	$167,360,271
3	PTGX	Protagonist Therapeutics, Inc	1,414,173	$149,053,834
4	RCUS	Arcus Biosciences, Inc.	3,777,798	$81,600,436
5	ALNY	Alnylam Pharmaceuticals, Inc.	243,883	$80,693,568
6	SRRK	Scholar Rock Holding Corp	1,500,470	$73,763,105
7	RYTM	Rhythm Pharmaceuticals, Inc.	758,891	$66,000,750
8	CYTK	Cytokinetics Inc	1,000,428	$65,938,209

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,900,507	3,300,169	+44.7%	Shares	Sole	2026-05-15
2025-12-31	$7,959,932	2,280,783	+28.9%	Shares	Sole	2026-02-17
2025-09-30	$5,380,942	1,770,047	-40.3%	Shares	Sole	2025-11-14
2025-06-30	$7,622,892	2,966,106	+113.2%	Shares	Sole	2025-08-14
2025-03-31	$3,492,024	1,391,245	+32.9%	Shares	Sole	2025-05-15
2024-12-31	$2,743,074	1,046,975	-49.9%	Shares	Sole	2025-02-14
2024-09-30	$7,986,859	2,090,801	+41.7%	Shares	Sole	2024-11-14
2024-06-30	$4,543,234	1,475,076	+0.1%	Shares	Sole	2024-08-14
2024-03-31	$8,373,370	1,474,185	+742.4%	Shares	Sole	2024-05-15
2021-09-30	$2,035,250	175,000	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.